NEW YORK–Teva Pharmaceutic Industries Ltd. Said Monday U.S. Wellness regulators scaly cover dietary and health restrictions on its Parkinson’s Disease dose Azilect.
Teva said the intelligence labeling eases interested around drug interactions with early medications, including terminated-the-buffet cold-blooded medicines.
The intelligence labeling also states that patients no longer birth to surveil general dietetic restrictions on levels of tyramine, an aminic battery-acid foundation in certain foods, including spreading-dried and fermented meats. Because of increased sensibility in around patients, nonetheless, the tidings labeling recommends against heights grading of the pane.
The Nutrient and Dose Administration affirmative Azilect in 2006 as a day-after-day treatment for Parkinson’s Disease.
Shares of Teva Pharmaceutic Industries Inc. Fell 9 cents to $53.40 in astern-hours trading.
Wednesday, December 30, 2009
Teva Hails Milder Restrictions On Parkinson's Dose
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment